ANTIPROLIFERATIVE, PROAPOPTOTIC, AND TUMOR-SUPPRESSING EFFECTS OF THE NOVEL ANTICANCER AGENT ALSEVIRONE IN PROSTATE CANCER CELLS AND XENOGRAFTS Article Khan I.I., Karshieva S.S., Sokolova D.V., Spirina T.S., Zolottsev V.A., Latysheva A.S., Anisimova N.Y., Komarova M.V., Yakunina M.N., Nitetskaya T.A., Misharin A.Y., Pokrovsky V.S. Archiv der Pharmazie. 2021.
MECHANISMS OF THE ANTIPROLIFERATIVE AND ANTITUMOR ACTIVITY OF NOVEL TELOMERASE-CARBONIC ANHYDRASE DUAL-HYBRID INHIBITORS Article Plyasova A.A., Berrino E., Khan I.I., Veselovsky A.V., Pokrovsky V.S., Angeli A., Ferraroni M., Supuran C.T., Pokrovskaya M.V., Alexandrova S.S., Gladilina Y.A., Sokolov N.N., Hilal A., Carta F., Zhdanov D.D. Journal of Medicinal Chemistry. American Chemical Society. Vol. 64. 2021. P. 11432-11444
PROMISING APPLICATIONS OF STEROID СONJUGATES FOR CANCER RESEARCH AND TREATMENT Article Latysheva А.S., Pokrovsky V.S., Khan I.I., Misharin A.Y., А. Zolottsev V. European Journal of Medicinal Chemistry. Elsevier Masson SAS. Vol. 210. 2021.
STEROID CONJUGATES AS POTENTIAL ANTI-CANCER AGENTS Article Zolottsev V.A., Latysheva A.S., Pokrovsky V.S., Khan I.I., Almanza R.L., Misharin A.Y. Российский биотерапевтический журнал. Федеральное государственное бюджетное учреждение "Российский онкологический научный центр им. Н.Н.Блохина" Российской академии медицинских наук. Vol. 19. 2020. P. 22-52
COMPARISON OF DIFFERENT METHODS FOR DETERMINING THE CRITICAL MICELLE CONCENTRATION Article Khan I.I., Parfait K., Sachivkina N.P. Farmatsiya. Первый Московский государственный медицинский университет им. И.М. Сеченова. Vol. 67. 2018. P. 35-38